BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) Return on equity 2024–2025
BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
5.9%FY2025 · since FY2024: -30.1% → 5.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 5.9% | +36.0 pp |
| FY2024 | -30.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BHIC financial trends
BHIC RevenueBHIC Net incomeBHIC Net marginBHIC Gross profitBHIC Gross marginBHIC Operating incomeBHIC Operating marginBHIC Operating cash flowBHIC Free cash flowBHIC Capital expendituresBHIC Stock buybacksBHIC Dividends paidBHIC Total assetsBHIC Total liabilitiesBHIC Shareholders’ equityBHIC overview →